Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer

NCT00045591 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: celecoxib
DRUG: Celecoxib

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]